rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Grant C. Bogle

Director

Company insider

Files Form 4 as: Director, Nuvalent; President and CEO, Epizyme; Sr. VP, Chief Commercial Ofc, Tesaro.

Every Form 4 they filed

In numbers

Trades disclosed
59
Buys
0
Sells
3
Bought
$0
Sold
$2.3M
Companies
3
Companies where not an officer
1
First trade
13 Jul 2015
Last trade
15 Jul 2026
Last filed
15 Jul 2026

Companies traded

Where they are an officer
EpizymeDirector, Officer · last 12 Aug 20220 buys · 0 sells
TesaroOfficer · last 22 Jan 20190 buys · 3 sells
Everywhere else they filed: board seats, 10% stakes, other companies
NuvalentDirector · Biotechnology · last 15 Jul 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jul 2026filed 15 Jul 2026NuvalentBiotechnologySEC FORM 4 Code U$461K3,714 at $124.00filing
15 Jul 2026filed 15 Jul 2026NuvalentBiotechnologySEC FORM 4 Code D—5,577filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—4,851filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—4,851filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—4,147filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—4,147filing
15 Jul 2026filed 15 Jul 2026NuvalentSEC FORM 4 Code U$461K3,714 at $124.00filing
15 Jul 2026filed 15 Jul 2026NuvalentSEC FORM 4 Code D—5,577filing
16 Jun 2026filed 18 Jun 2026NuvalentBiotechnologySEC FORM 4 Code A—3,444 at $0.00filing
16 Jun 2026filed 18 Jun 2026NuvalentSEC FORM 4 Code A—3,444 at $0.00filing
18 Jun 2025filed 20 Jun 2025Nuvalentoption or derivativeSEC FORM 4 Code A—4,147 at $0.00filing
18 Jun 2025filed 20 Jun 2025NuvalentSEC FORM 4 Code A—2,647 at $0.00filing
5 Dec 2024filed 9 Dec 2024Nuvalentoption or derivativeSEC FORM 4 Code A—4,851 at $0.00filing
5 Dec 2024filed 9 Dec 2024NuvalentSEC FORM 4 Code A—3,200 at $0.00filing
12 Aug 2022filed 16 Aug 2022EpizymeSEC FORM 4 Code D—84,170filing
12 Aug 2022filed 16 Aug 2022EpizymeSEC FORM 4 Code D—175,000filing
9 Aug 2022filed 11 Aug 2022Epizymeoption or derivativeSEC FORM 4 Code M—800,000 at $0.00filing
9 Aug 2022filed 11 Aug 2022Epizymeoption or derivativeSEC FORM 4 Code M—417,500 at $0.00filing
9 Aug 2022filed 11 Aug 2022EpizymeSEC FORM 4 Code M$1.1M800,000 at $1.39filing
9 Aug 2022filed 11 Aug 2022EpizymeSEC FORM 4 Code F$1.0M746,307 at $1.39filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.